RDUS

Radius Health, Inc. - Common Stock

$28.32 +$0.28 +0.99%



Shares Bought10
Shares Sold10
Total20
Shares Owned0
Last Price$28.32
Total Return-$32.08
Range Today$27.82 - $28.55
52 Week Range$24.66 - $55.30
Open$27.82
Market Cap$1.26B
Volume/Average311.89K/956.95K
P/E Ratio-
Dividend/Yield-




Radius Health, Inc. engages in the discovery and development of therapeutics for the treatment of osteoporosis, oncology, and endocrine diseases. The firm's lead product, abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes abaloparatide transdermal patch for potential use in osteoporosis and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Waltham, MA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
09-11-17 18:46 09-15-17 14:18 $35.93 $32.24 -$3.69 -10.26% amc7
09-07-17 16:55 09-15-17 14:17 $36.09 $32.20 -$3.89 -10.79% crizisaround amc7
09-07-17 16:52 09-15-17 14:07 $36.10 $32.01 -$4.09 -11.33% crizisaround amc7
08-25-17 14:46 09-15-17 14:01 $36.62 $31.92 -$4.70 -12.83% crizisaround amc7
08-25-17 14:45 09-14-17 20:27 $36.64 $32.82 -$3.82 -10.43% amc7
08-25-17 14:44 09-14-17 20:26 $36.65 $32.82 -$3.83 -10.45% amc7
08-25-17 14:43 09-14-17 20:25 $36.66 $32.83 -$3.83 -10.45% crizisaround amc7
09-14-17 14:14 09-14-17 20:24 $33.38 $32.83 -$0.55 -1.66% crizisaround
08-25-17 14:41 09-14-17 17:45 $36.61 $32.89 -$3.72 -10.16% crizisaround amc7
08-25-17 14:39 09-06-17 20:14 $36.65 $36.70 +$0.05 +0.14% crizisaround xvpulsevx amc7